Infinium Pharmachem Limited (NSE:INFINIUM)

Market Cap	3.34B
Revenue (ttm)	1.57B
Net Income (ttm)	93.40M
Shares Out	15.58M
EPS (ttm)	6.07
PE Ratio	35.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	2,325
Open	223.50
Previous Close	215.00
Day's Range	214.50 - 223.50
52-Week Range	210.00 - 337.00
Beta	0.22
RSI	39.23
Earnings Date	Feb 12, 2026

About Infinium Pharmachem

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and inte...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 144
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFINIUM

Financial Performance

In 2024, Infinium Pharmachem's revenue was 1.56 billion, an increase of 14.78% compared to the previous year's 1.36 billion. Earnings were 81.45 million, a decrease of -27.93%.